Patents by Inventor Paul B. Chretien

Paul B. Chretien has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating hepatitis C in non-responders to interferon treatment
    Patent number: 6001799
    Abstract: A method of treating Hepatitis C by administering an immune system-potentiating dose of at least one Thymosin or system-potentiating Thymosin fragment to a mammal infected with Hepatitis C virus, which Hepatitis C infection in the mammal is non-responsive to treatment with interferon alone.
    Type: Grant
    Filed: March 5, 1993
    Date of Patent: December 14, 1999
    Assignees: SciClone Pharmaceuticals, Inc., The Board of Governors of Wayne State University
    Inventors: Paul B. Chretien, Milton Mutchnick
  • Method and composition for treatment of patients having decompensated liver disease
    Patent number: 5750501
    Abstract: A method and composition for treating a Hepatitis B patient having hepatic decompensation utilizes Hepatitis B virus-reducing amounts of T.alpha..sub.1, administered to a patient having decompensated liver disease so as to render the patient seronegative for Hepatitis B virus DNA.
    Type: Grant
    Filed: September 26, 1996
    Date of Patent: May 12, 1998
    Assignees: Alpha 1 Biomedicals, Inc., The Board of Governors of Wayne State Univ.
    Inventors: Paul B. Chretien, Milton G. Mutchnick
  • Method for treatment of autoimmune hepatitis
    Patent number: 5468729
    Abstract: A method and composition for treating autoimmune hepatitis in a patient utilizes an immunomodulatory amount of T.alpha..sub.1 and an anti-inflammatory amount of a corticosteroid.
    Type: Grant
    Filed: October 26, 1993
    Date of Patent: November 21, 1995
    Assignees: Alpha 1 Biomedicals, The Board of Governers of Wayne State University
    Inventors: Paul B. Chretien, Milton G. Mutchnick